ETON
Price
$16.63
Change
-$0.34 (-2.00%)
Updated
May 6 closing price
Capitalization
96.33M
One day until earnings call
FDMT
Price
$3.08
Change
-$0.49 (-13.73%)
Updated
May 6 closing price
Capitalization
165.38M
One day until earnings call
Ad is loading...

ETON vs FDMT

Header iconETON vs FDMT Comparison
Open Charts ETON vs FDMTBanner chart's image
Eton Pharmaceuticals
Price$16.63
Change-$0.34 (-2.00%)
Volume$185.55K
Capitalization96.33M
4D Molecular Therapeutics
Price$3.08
Change-$0.49 (-13.73%)
Volume$410.95K
Capitalization165.38M
ETON vs FDMT Comparison Chart
Loading...
ETON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ETON vs. FDMT commentary
May 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETON is a Buy and FDMT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 07, 2025
Stock price -- (ETON: $16.63 vs. FDMT: $3.57)
Brand notoriety: ETON and FDMT are both not notable
ETON represents the Pharmaceuticals: Other, while FDMT is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETON: 80% vs. FDMT: 61%
Market capitalization -- ETON: $96.33M vs. FDMT: $165.38M
ETON [@Pharmaceuticals: Other] is valued at $96.33M. FDMT’s [@Biotechnology] market capitalization is $165.38M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $309.18B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETON’s FA Score shows that 2 FA rating(s) are green whileFDMT’s FA Score has 0 green FA rating(s).

  • ETON’s FA Score: 2 green, 3 red.
  • FDMT’s FA Score: 0 green, 5 red.
According to our system of comparison, ETON is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETON’s TA Score shows that 6 TA indicator(s) are bullish while FDMT’s TA Score has 4 bullish TA indicator(s).

  • ETON’s TA Score: 6 bullish, 3 bearish.
  • FDMT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ETON is a better buy in the short-term than FDMT.

Price Growth

ETON (@Pharmaceuticals: Other) experienced а +0.85% price change this week, while FDMT (@Biotechnology) price change was +6.89% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.89%. For the same industry, the average monthly price growth was +7.87%, and the average quarterly price growth was +63.07%.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.32%. For the same industry, the average monthly price growth was +9.19%, and the average quarterly price growth was -13.77%.

Reported Earning Dates

ETON is expected to report earnings on Aug 07, 2025.

FDMT is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.89% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Biotechnology (-2.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FDMT($165M) has a higher market cap than ETON($96.3M). ETON YTD gains are higher at: 24.850 vs. FDMT (-44.704). ETON has higher annual earnings (EBITDA): -291K vs. FDMT (-181.14M). FDMT has more cash in the bank: 425M vs. ETON (21.4M). ETON has less debt than FDMT: ETON (5.4M) vs FDMT (24.6M). ETON has higher revenues than FDMT: ETON (31.6M) vs FDMT (37K).
ETONFDMTETON / FDMT
Capitalization96.3M165M58%
EBITDA-291K-181.14M0%
Gain YTD24.850-44.704-56%
P/E Ratio49.33N/A-
Revenue31.6M37K85,405%
Total Cash21.4M425M5%
Total Debt5.4M24.6M22%
FUNDAMENTALS RATINGS
ETON: Fundamental Ratings
ETON
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
24
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ETONFDMT
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
ETON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCNAX40.98N/A
N/A
Fidelity Advisor Consumer Discret A
SIECX11.54N/A
N/A
Saratoga International Equity C
THORX39.05N/A
N/A
Thornburg Global Opportunities R3
CZMGX19.38N/A
N/A
Multi-Manager Growth Strategies Inst
TMITX9.95N/A
N/A
Transamerica Mid Cap Growth I3

ETON and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETON has been loosely correlated with MDGL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ETON jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETON
1D Price
Change %
ETON100%
-2.00%
MDGL - ETON
34%
Loosely correlated
-3.67%
VKTX - ETON
31%
Poorly correlated
-8.41%
LBTSF - ETON
30%
Poorly correlated
N/A
ARRY - ETON
30%
Poorly correlated
+4.46%
HROW - ETON
29%
Poorly correlated
-2.47%
More

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with RGNX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
-13.73%
RGNX - FDMT
44%
Loosely correlated
-18.85%
STOK - FDMT
44%
Loosely correlated
-9.79%
IMNM - FDMT
41%
Loosely correlated
-10.29%
IDYA - FDMT
41%
Loosely correlated
-13.29%
KYMR - FDMT
41%
Loosely correlated
-14.92%
More